Your browser doesn't support javascript.
loading
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer.
Feng, Mei; Wu, Zhongen; Zhou, Yan; Wei, Zhuang; Tian, Enming; Mei, Shenglin; Zhu, Yuanyuan; Liu, Chenglong; He, Fenglian; Li, Huiyu; Xie, Cao; Jin, Joy; Dong, Jibin; Yang, Dehua; Yu, Ker; Qian, Junbin; Lambrechts, Diether; Wang, Ming-Wei; Zhu, Di.
Afiliação
  • Feng M; Department of Pharmacology, School of Basic Medical Sciences and School of Pharmacy, Fudan University, Shanghai, China.
  • Wu Z; School of Pharmacy, Fudan University, Shanghai, China.
  • Zhou Y; Key Laboratory of Systems Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Wei Z; Clinical Translational Research Center, Shanghai Pulmonary Hospital, School of Life Science and Technology, Tongji University, Shanghai, China.
  • Tian E; School of Pharmacy, Fudan University, Shanghai, China.
  • Mei S; School of Medicine, University of California at San Francisco, San Francisco, CA, USA.
  • Zhu Y; School of Pharmacy, Fudan University, Shanghai, China.
  • Liu C; School of Pharmacy, Fudan University, Shanghai, China.
  • He F; School of Pharmacy, Fudan University, Shanghai, China.
  • Li H; School of Pharmacy, Fudan University, Shanghai, China.
  • Xie C; School of Pharmacy, Fudan University, Shanghai, China.
  • Jin J; Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Dong J; School of Pharmacy, Fudan University, Shanghai, China.
  • Yang D; Key Laboratory of Systems Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Yu K; School of Pharmacy, Fudan University, Shanghai, China.
  • Qian J; VIB Center for Cancer Biology and Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
  • Lambrechts D; School of Life Science and Technology, ShanghaiTech University, Shanghai, China. diether.lambrechts@kuleuven.be.
  • Wang MW; Department of Pharmacology, School of Basic Medical Sciences and School of Pharmacy, Fudan University, Shanghai, China. mwwang@simm.ac.cn.
  • Zhu D; School of Pharmacy, Fudan University, Shanghai, China. mwwang@simm.ac.cn.
Signal Transduct Target Ther ; 6(1): 313, 2021 08 20.
Article em En | MEDLINE | ID: mdl-34417435
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Antígenos de Diferenciação de Linfócitos T / Antígenos CD / Neoplasias do Colo / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Antígenos de Diferenciação de Linfócitos T / Antígenos CD / Neoplasias do Colo / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article